Effects of priming dose schedules in cytoxan treatment of mouse leukemia L1210.
D000818:Animals; D002470:Cell Survival; D002478:Cells, Cultured; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D009368:Neoplasm Transplantation; D014184:Transplantation, Homologous
D003520:Cyclophosphamide